83 FR 57743 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 222 (November 16, 2018)

Page Range57743-57743
FR Document2018-24998

Federal Register, Volume 83 Issue 222 (Friday, November 16, 2018)
[Federal Register Volume 83, Number 222 (Friday, November 16, 2018)]
[Notices]
[Page 57743]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-24998]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Consortia for HIV/AIDS Vaccine 
Development (CHAVD) (UM1 Clinical Trial Not Allowed).
    Date: December 3-4, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 
8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Roberta Binder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G21A, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5050, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Autoimmunity Centers of Excellence, 
Clinical Research Program (UM1 Clinical Trial Required).
    Date: December 4-5, 2018.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The William F. Bolger Center, 9600 Newbridge Drive, 
Potomac, MD 20854.
    Contact Person: Zhuqing (Charlie) Li, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room # 3G41B, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC9823, Bethesda, MD 20892-9823, (240) 669-5068, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 9, 2018.
Natasha M. Copeland,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24998 Filed 11-15-18; 8:45 am]
 BILLING CODE 4140-01-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesDecember 3-4, 2018.
FR Citation83 FR 57743 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR